Ying‐Bo Li

721 total citations
17 papers, 595 citations indexed

About

Ying‐Bo Li is a scholar working on Molecular Biology, Molecular Medicine and Organic Chemistry. According to data from OpenAlex, Ying‐Bo Li has authored 17 papers receiving a total of 595 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Molecular Medicine and 2 papers in Organic Chemistry. Recurrent topics in Ying‐Bo Li's work include Genomics, phytochemicals, and oxidative stress (3 papers), Curcumin's Biomedical Applications (3 papers) and Synthesis and biological activity (2 papers). Ying‐Bo Li is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (3 papers), Curcumin's Biomedical Applications (3 papers) and Synthesis and biological activity (2 papers). Ying‐Bo Li collaborates with scholars based in China, Macao and United States. Ying‐Bo Li's co-authors include Hongli Wu, Xue-Jun Li, Ying Xu, Yuhua Li, Yitao Wang, Jiabin Guo, Zhangfeng Zhong, Guosheng Wu, Xiuping Chen and Wen Siang Tan and has published in prestigious journals such as Advanced Materials, PLoS ONE and Journal of Controlled Release.

In The Last Decade

Ying‐Bo Li

16 papers receiving 583 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ying‐Bo Li China 10 226 145 139 94 80 17 595
Sita Sharan Patel India 14 300 1.3× 183 1.3× 78 0.6× 43 0.5× 104 1.3× 20 809
Elisa Nicoloso Simões Pires Brazil 9 117 0.5× 66 0.5× 126 0.9× 85 0.9× 145 1.8× 14 487
Kwang-Ho Ko South Korea 7 253 1.1× 83 0.6× 77 0.6× 237 2.5× 71 0.9× 9 638
Virginia Zbarsky United Kingdom 15 242 1.1× 85 0.6× 100 0.7× 289 3.1× 145 1.8× 16 946
Stephanie Hagl Germany 17 424 1.9× 89 0.6× 126 0.9× 103 1.1× 382 4.8× 24 911
Fanny Longpré Canada 9 254 1.1× 36 0.2× 81 0.6× 83 0.9× 202 2.5× 10 837
Chandra Sekhar Kuruva United States 7 303 1.3× 117 0.8× 144 1.0× 55 0.6× 386 4.8× 12 707
Tianfang Jiang China 9 305 1.3× 55 0.4× 138 1.0× 166 1.8× 302 3.8× 15 1.0k
Yale Duan China 11 197 0.9× 102 0.7× 92 0.7× 130 1.4× 185 2.3× 17 554
Udaiyappan Janakiraman India 9 118 0.5× 43 0.3× 80 0.6× 85 0.9× 120 1.5× 12 484

Countries citing papers authored by Ying‐Bo Li

Since Specialization
Citations

This map shows the geographic impact of Ying‐Bo Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying‐Bo Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying‐Bo Li more than expected).

Fields of papers citing papers by Ying‐Bo Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying‐Bo Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying‐Bo Li. The network helps show where Ying‐Bo Li may publish in the future.

Co-authorship network of co-authors of Ying‐Bo Li

This figure shows the co-authorship network connecting the top 25 collaborators of Ying‐Bo Li. A scholar is included among the top collaborators of Ying‐Bo Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying‐Bo Li. Ying‐Bo Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Yang, Xue, Zhi‐Qi Zhang, Jie Yang, et al.. (2025). Fe/Mo‐Based Lipid Peroxidation Nanoamplifier Combined with Adenosine Immunometabolism Regulation to Augment Anti‐Breast Cancer Immunity. Advanced Materials. 37(8). e2419120–e2419120. 9 indexed citations
2.
Wang, Fudi, Yingying Shi, Jiawen Zhang, et al.. (2025). Engineering sialylated N-glycans on adeno-associated virus capsids for targeted gene delivery and therapeutic applications. Journal of Controlled Release. 380. 563–578. 1 indexed citations
3.
Xu, Jin, Yongping Song, Tianqi Fan, et al.. (2025). Obstructive sleep apnea-associated hypertensive disorders in pregnancy: a literature review and clinical management strategies. Reproductive Biology and Endocrinology. 23(1). 114–114.
5.
Li, Ying‐Bo, Zhenli Li, Ruiwen Zhang, et al.. (2024). Design and synthesis of hemicyanine-based NIRF probe for detecting Aβ aggregates in Alzheimer’s disease. Bioorganic Chemistry. 150. 107514–107514. 4 indexed citations
6.
Cai, Yi, et al.. (2020). <p>Eicosapentaenoic acid’s metabolism of 15-LOX-1 promotes the expression of miR-101 thus inhibits Cox2 pathway in colon cancer</p>. OncoTargets and Therapy. Volume 13. 5605–5616. 7 indexed citations
7.
Li, Ying‐Bo, et al.. (2016). Detection and tracking of overlapping cell nuclei for large scale mitosis analyses. BMC Bioinformatics. 17(1). 183–183. 11 indexed citations
8.
Li, Ridong, Huiling Wang, Ying‐Bo Li, et al.. (2015). Discovery and optimization of novel dual dithiocarbamates as potent anticancer agents. European Journal of Medicinal Chemistry. 93. 381–391. 44 indexed citations
9.
Li, Ying‐Bo, Jinxi Wang, Weihua Han, et al.. (2014). c-Met Targeting Enhances the Effect of Irradiation and Chemical Agents against Malignant Colon Cells Harboring a KRAS Mutation. PLoS ONE. 9(11). e113186–e113186. 17 indexed citations
10.
Li, Ying‐Bo, Jian‐Li Gao, Zhangfeng Zhong, et al.. (2013). Bisdemethoxycurcumin suppresses MCF-7 cells proliferation by inducing ROS accumulation and modulating senescence-related pathways. Pharmacological Reports. 65(3). 700–709. 50 indexed citations
11.
Li, Ying‐Bo, Zhangfeng Zhong, Meiwan Chen, et al.. (2013). Bisdemethoxycurcumin Increases Sirt1 to Antagonizet-BHP-Induced Premature Senescence in WI38 Fibroblast Cells. Evidence-based Complementary and Alternative Medicine. 2013. 1–9. 14 indexed citations
12.
Li, Ying‐Bo, Zhongqing Wang, Xu Yan, et al.. (2013). IC-4, a new irreversible EGFR inhibitor, exhibits prominent anti-tumor and anti-angiogenesis activities. Cancer Letters. 340(1). 88–96. 22 indexed citations
13.
Zhong, Zhangfeng, Ying‐Bo Li, Wen Siang Tan, et al.. (2012). Furanodiene enhances tamoxifen‐induced growth inhibitory activity of ERa‐positive breast cancer cells in a PPARγ independent manner. Journal of Cellular Biochemistry. 113(8). 2643–2651. 25 indexed citations
14.
Wu, Guosheng, Jin‐Jian Lu, Jiajie Guo, et al.. (2011). Ganoderic acid DM, a natural triterpenoid, induces DNA damage, G1 cell cycle arrest and apoptosis in human breast cancer cells. Fitoterapia. 83(2). 408–414. 118 indexed citations
15.
Wang, Rui, Yuhua Li, Ying Xu, et al.. (2009). Curcumin produces neuroprotective effects via activating brain-derived neurotrophic factor/TrkB-dependent MAPK and PI-3K cascades in rodent cortical neurons. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 34(1). 147–153. 105 indexed citations
16.
Xu, Ying, Hongli Wu, Ying‐Bo Li, et al.. (2007). The antidepressant effects of curcumin in the forced swimming test involve 5-HT1 and 5-HT2 receptors. European Journal of Pharmacology. 578(1). 43–50. 156 indexed citations
17.
Wang, Shali, Ying‐Bo Li, Yaping Wang, & Min Feng. (2007). [Effect of TSPG on proliferation and differentiation of human embryonic neural stem cell into dopaminergic neuron].. PubMed. 32(13). 1310–3. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026